Eteplirsen

Category: Genetic Disorders



Eteplirsen Overview

Eteplirsen (brand name Exondys 51) is a medication to treat, but not a cure, some types of Duchenne muscular dystrophy (DMD), caused by a specific mutation. Eteplirsen only targets specific mutations and thus is only useful in just over 1% of cases.[1] After a debate surrounding the efficacy of the drug, eteplirsen received accelerated approval from the US Food and Drug administration in late 2016.[2][3] A year's worth of treatment is expected t...

Read more Eteplirsen Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Eteplirsen

Recent Eteplirsen Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Eteplirsen
  • Solution: 100mg/2ml (50mg/ml), 500mg/10ml (50mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Eteplirsen or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA